Caption Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Caption Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-319,300	Closed	-$6.02M	–	1094
2019 Q3	$6.02M	Buy	+319,300	New	+$3.65M	0.31%	88

Caption Management's ALDR Position: Q1 2019 in Review

Caption Management sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 10,000 shares — an estimated $103K sold.

Caption Management first reported a position in ALDR in Q4 2018 and held it in 1 quarter. The position peaked at $103K in Q4 2018. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

Caption Management reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
Caption Management sold 10,000 Alder Biopharmaceuticals shares in Q1 2019, an estimated $103K.
Caption Management first reported a position in Alder Biopharmaceuticals in Q4 2018 and held it in 1 quarter.
Caption Management's Alder Biopharmaceuticals position peaked at $103K in Q4 2018.
123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on Caption Management's 13F filing for Q1 2019, filed 14 May 2019.